We found that CD8+BCL-2+ T cells displayed a significantly higher proportion and MFI of PD-1+Tim-3+ cells than CD8+BCL-2−T cells in patients with CLL. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.